ElendiLabs
Evaluation Fees: While the HAS itself does not charge a direct 'fee' for evaluating the dossier, the indirect costs are substantial. Preparing an LPPR dossier with robust clinical evidence and a Budget Impact Analysis (BIA) typically costs between €30,000 and €60,000 in consultancy fees. • PECAN Costs: The PECAN pathway requires a specific technical certification from ANS (Digital Health Agency) first. This adds an extra layer of cost (approx. €5,000 - €10,000 for cybersecurity and interoperability audits). However, the 2026 fixed compensation (up to €780 per patient/year) during the transition period usually justifies this upfront investment.
Anonymous
We are targeting the French public health insurance reimbursement (LPPR) for our new digital therapeutic. In 2026, what is the cost associated with submitting a dossier to the CNEDiMTS (HAS)? Specifically, if we opt for the PECAN (one-year early coverage) pathway for innovative devices, how much should we budget for the 'organizational benefit' analysis compared to a standard submission?